Biotechnology News

March 27, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) today announced the appointment of Dr. George Farmer as VP Corporate Development, where he will lead the communications, competitive intelligence and strategy functions.

March 27, 2012

FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--Fujitsu and Medi+Sphere Development Planning Strategic Alliance to Deliver Customized NuVola Private Cloud Appliances to the Global Healthcare Market

March 27, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that the Company will...

March 27, 2012

CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)--AliveCor announced results from a study that demonstrated how the company’s ECG monitoring device allows users to learn and characterize their heart rates by using the hand-held device.

March 27, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical...

March 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Constellation Pharmaceuticals, Inc., a leading biopharmaceutical company in the field of epigenetics, today announced the appointment of Keith E. Dionne, Ph.D., to the role of president and chief executive...

March 27, 2012

BOSTON--(BUSINESS WIRE)--Third Rock Ventures, LLC, a venture capital firm focused on building life sciences companies, today announced the appointment of Mark A. Goldsmith, M.D., Ph.D., to the role of venture partner in the firm’s San Francisco...

March 27, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics today announced the Company has appointed John P. Shannon, former senior executive at Baxter Healthcare, to the newly created position of Chief Commercial Officer. Mr. Shannon brings to...

March 27, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Needham and Company 11th Annual Healthcare Conference, being held April 3-4, 2012 at the New York Palace Hotel in New...

March 27, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Roger Tung, CEO of Concert Pharmaceuticals, will present at the Needham Healthcare Conference

March 27, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with a primary focus in oncology and hematology, announced today the launch of the Company's new patient campaign for ZEVALIN (ibritumomab...

March 27, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--S2 Security now offers a video solution for enterprise customers: NetVR version 1.1. This solution offers advanced video forensics and tight integration of access control and monitoring with video.

March 27, 2012

LOS ANGELES--(BUSINESS WIRE)--Tommy Lasorda will help educate Americans and their physicians that you can restore heart health and maintain an active lifestyle with a BIOTRONIK pacemaker; first Program announced for March 28th

March 27, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific announces launch of BalanCD™ Cell Culture Media Product Line.

March 27, 2012

POMPEY, France & SHANGHAI--(BUSINESS WIRE)--Novasep, a leading supplier of manufacturing solutions to the life sciences industries, today announces the opening of a new 2,000 m2 facility in Shanghai Pudong district, China. The site will boost...

March 26, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics announces full exercise of the over-allotment option granted to the underwriter bringing total gross proceeds to approximately $12 million.

March 26, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Kips Bay Medical Announces Move to NASDAQ Capital Market

March 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem and co-founder, Robert Weinberg, to present at the 2012 AACR Annual Meeting. Dr. Weinberg has been awarded the 2012 Pezcoller Foundation-AACR International Award for Cancer Research.

March 26, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the Journal of Clinical Oncology (JCO) published results of the company’s pivotal clinical trial of ADCETRIS™ (brentuximab vedotin) in Hodgkin lymphoma (HL...

March 26, 2012

BELLOWS FALLS, Vt.--(BUSINESS WIRE)--Continuing in its mission of manufacturing while protecting the global environment, it was announced that Chroma Technology Corp. has been certified a Green Partner by Sony Corporation.

March 26, 2012

LONGMONT, Colo.--(BUSINESS WIRE)--nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, today announced that 2011 earnings before interest and taxes were up 40% when compared to 2010.

March 26, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Companies seeking to out-license a drug in clinical development will spend an average of $86,000 to identify buyers, according to a study by pharmaceutical research firm Cutting Edge Information

March 26, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, today announced results of analyses of...

March 26, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent International AB (OMXS: BINV) At BioInvent’s Annual General Meeting on 26 March, CEO Svein Mathisen informed the shareholders about the Company´s progress. His presentation concluded that...

March 26, 2012

OSLO, Norway--(BUSINESS WIRE)--DiaGenic and GE Healthcare to develop blood-based test for mild cognitive impairment (MCI), a disorder associated with risk for Alzheimer’s Disease

March 26, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today that it has entered into a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) and a Consent to Final Judgment (Consent Agreement) with the U.S. Securities and...

March 26, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA (OSE:DIAG) today announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic’s peripheral gene expression profiling in patients with...

March 26, 2012

CHIBA, Japan & SAN DIEGO--(BUSINESS WIRE)--Japan-based Transparent, Inc., and Molecular Response of San Diego execute co-marketing and distribution rights to launch novel ex-vivo 3D cell culture system focused on applications in oncology

March 26, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) and associate SG Austria announced a new, unique, and specialized encapsulated cell gene expression induction system.

March 26, 2012

EXTON, Pa.--(BUSINESS WIRE)--Following the loss of patent exclusivity in late 2011, Pfizer’s Xalatan has lost three-quarters of its share to generic latanoprost.

March 26, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

March 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a second letter to its...

March 26, 2012

CHICAGO & SANTA BARBARA, Calif.--(BUSINESS WIRE)--MarketMonitors, Inc. (MMI), a provider of online business intelligence and analytic databases, announced today the international launch of its new Drug-Resistant Hypertension (HTN) sector for...

March 26, 2012

SAN DIEGO--(BUSINESS WIRE)--At the American Chemical Society’s Spring 2012 National Meeting & Expo, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its...

March 26, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Cook Medical is pleased to announce the introduction of two bone biopsy products, the Osteo-Site® Ratchet™ and the Osteo-Site® coaxial bone biopsy needle set.

March 26, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved QNASLTM Nasal Aerosol, a new, “dry” nasal aerosol corticosteroid that treats seasonal nasal and year-...

March 26, 2012

MONTREAL--(BUSINESS WIRE)--Sunshine Biopharma, Inc. (OTCBB: SBFM), which has designed and synthesized a new compound, Adva-27a, that acts as an inhibitor of multidrug resistant breast cancer cells in vitro, today announced that it will be...

March 26, 2012

LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, announced today the addition of Stephanie H. Astrow, Ph.D., as the Company’s...

March 26, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizer’s early-stage compounds, including data from Pfizer’s investigational antibody-drug conjugate (ADC) portfolio and research...

March 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced its schedule of preclinical data presentations to be made at the American Association for Cancer Research (AACR) Annual Meeting 2012, taking place...

March 26, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report second-quarter results on April 27, 2012, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:...

March 26, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes announced that Chief Executive Officer Shai N. Gozani, M.D., Ph.D. has...

March 26, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

March 26, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. announced today that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.

March 26, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Today Vitrolife (STO:VITR) is publishing the Annual Report for 2011 in Swedish. The Annual Report is attached to this press release and will also be available on...

March 26, 2012

NEW YORK & LAUSANNE, Switzerland & LONDON--(BUSINESS WIRE)--Celtic Therapeutics Management, a private equity firm focused on novel therapeutics, launches Swiss based company: ADC Therapeutics with 10 ADC oncology development programs...

March 26, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Michael J. Fox Foundation Invests $179 Million in the Fight Against Parkinson’s Disease